Latest Insider Transactions at Exelixis, Inc. (EXEL)
This section provides a real-time view of insider transactions for Exelixis, Inc. (EXEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EXELIXIS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EXELIXIS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 06
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Grant, award, or other acquisition
|
Direct |
50,660
+10.11%
|
-
|
|
Sep 06
2023
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,147
-2.73%
|
$377,234
$22.27 P/Share
|
|
Sep 06
2023
|
Christopher J. Senner EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
65,135
+9.39%
|
-
|
|
Sep 06
2023
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
46,608
-6.03%
|
$1,025,376
$22.27 P/Share
|
|
Sep 06
2023
|
Michael Morrissey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
188,005
+19.55%
|
-
|
|
Sep 06
2023
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
14,354
-2.31%
|
$315,788
$22.27 P/Share
|
|
Sep 06
2023
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
57,900
+8.51%
|
-
|
|
Sep 06
2023
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
14,354
-4.27%
|
$315,788
$22.27 P/Share
|
|
Sep 06
2023
|
Patrick J. Haley EVP, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
57,900
+14.69%
|
-
|
|
Sep 01
2023
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Indirect |
57,500
-4.12%
|
-
|
|
Aug 31
2023
|
Michael Morrissey President and CEO |
BUY
Bona fide gift
|
Indirect |
56,221
+3.87%
|
-
|
|
Aug 31
2023
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Direct |
56,221
-8.76%
|
-
|
|
Aug 30
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Open market or private sale
|
Direct |
4,600
-1.14%
|
$101,200
$22.47 P/Share
|
|
Aug 28
2023
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
303,779
-32.13%
|
$6,683,138
$22.18 P/Share
|
|
Aug 28
2023
|
Michael Morrissey President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
360,000
+27.58%
|
$5,400,000
$15.31 P/Share
|
|
Aug 24
2023
|
Amy C. Peterson EVP Prod Dev & Med Aff & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
240,000
+50.0%
|
-
|
|
Aug 15
2023
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,304
-3.83%
|
$489,384
$21.51 P/Share
|
|
Aug 15
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
6,280
-1.53%
|
$131,880
$21.51 P/Share
|
|
Aug 15
2023
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
7,177
-2.51%
|
$150,717
$21.51 P/Share
|
|
Aug 15
2023
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,177
-1.25%
|
$150,717
$21.51 P/Share
|
|
Aug 15
2023
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,074
-1.41%
|
$169,554
$21.51 P/Share
|
|
Aug 04
2023
|
Christopher J. Senner EVP and CFO |
SELL
Open market or private sale
|
Direct |
60,000
-9.5%
|
$1,200,000
$20.68 P/Share
|
|
Aug 04
2023
|
Christopher J. Senner EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+8.68%
|
$840,000
$14.74 P/Share
|
|
Aug 03
2023
|
Christopher J. Senner EVP and CFO |
SELL
Open market or private sale
|
Direct |
60,000
-9.5%
|
$1,200,000
$20.51 P/Share
|
|
Aug 03
2023
|
Christopher J. Senner EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+8.68%
|
$840,000
$14.74 P/Share
|
|
Aug 03
2023
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
30,553
-9.67%
|
$611,060
$20.67 P/Share
|
|
Aug 01
2023
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
55,710
-8.88%
|
$1,058,490
$19.63 P/Share
|
|
Aug 01
2023
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
55,710
+8.15%
|
$779,940
$14.74 P/Share
|
|
Jun 01
2023
|
George Poste Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,718
+8.83%
|
-
|
|
Jun 01
2023
|
Maria C Freire Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,718
+20.49%
|
-
|
|
Jun 01
2023
|
Jack L Wyszomierski Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,718
+5.77%
|
-
|
|
Jun 01
2023
|
Jacqueline Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,718
+28.59%
|
-
|
|
Jun 01
2023
|
Stelios Papadopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,718
+1.62%
|
-
|
|
May 31
2023
|
Tomas J. Heyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,176
+50.0%
|
-
|
|
May 31
2023
|
Bob Oliver Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,176
+50.0%
|
-
|
|
May 31
2023
|
David Edward Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,176
+50.0%
|
-
|
|
May 15
2023
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,967
-1.03%
|
$227,373
$19.18 P/Share
|
|
May 15
2023
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
33,518
-5.22%
|
$636,842
$19.18 P/Share
|
|
May 15
2023
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,446
-1.58%
|
$350,474
$19.18 P/Share
|
|
May 15
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
10,488
-1.25%
|
$199,272
$19.18 P/Share
|
|
May 15
2023
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
18,065
-1.83%
|
$343,235
$19.18 P/Share
|
|
Apr 05
2023
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
38,930
-6.27%
|
$778,600
$20.01 P/Share
|
|
Apr 05
2023
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
13,930
+2.19%
|
$195,020
$14.74 P/Share
|
|
Apr 03
2023
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
79,719
+11.6%
|
-
|
|
Apr 03
2023
|
Christopher J. Senner EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
85,414
+12.64%
|
-
|
|
Apr 03
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Grant, award, or other acquisition
|
Direct |
68,331
+14.0%
|
-
|
|
Apr 03
2023
|
Michael Morrissey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
313,185
+32.78%
|
-
|
|
Apr 03
2023
|
Patrick J. Haley EVP, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
79,719
+19.34%
|
-
|
|
Apr 03
2023
|
Vicki L Goodman EVP, Prod Dev & Med Aff &CMO |
BUY
Grant, award, or other acquisition
|
Direct |
82,566
+21.16%
|
-
|
|
Mar 10
2023
|
Jack L Wyszomierski Director |
SELL
Open market or private sale
|
Direct |
15,300
-4.6%
|
$244,800
$16.61 P/Share
|